E John Lee

Title: E John Lee: Innovator in Pharmaceutical Tablet Formulation

Introduction

E John Lee is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of non-sustained release tablet compositions. With a total of 2 patents to his name, his work has the potential to impact the pharmaceutical industry positively.

Latest Patents

E John Lee's latest patents include innovative formulations that enhance the effectiveness of pharmaceutical tablets. One of his patents focuses on a non-sustained release pharmaceutical tablet composition that comprises a rapidly precipitating drug in an amount from about 5 to about 60%. This formulation also includes a binder in an amount of from about 2 to about 25% and a superdisintegrant in an amount from about 6 to about 40%. The unique aspect of this invention is that the drug, binder, and superdisintegrant are mixed and compressed into a tablet without the need for heating, solvent, or grinding. Another patent, the Delavirdine high strength tablet formulation, shares similar characteristics and aims to improve the delivery of rapidly precipitating drugs.

Career Highlights

E John Lee is currently associated with Pharmacia & Upjohn Company, where he continues to innovate in the field of pharmaceutical sciences. His work has garnered attention for its potential to improve drug delivery systems and patient outcomes.

Collaborations

E John Lee has collaborated with talented coworkers such as Alice C Martino and Ashley H Bates. Their combined expertise contributes to the advancement of pharmaceutical technologies.

Conclusion

E John Lee's contributions to pharmaceutical tablet formulations demonstrate his commitment to innovation in the industry. His patents reflect a deep understanding of drug delivery mechanisms, which can lead to improved therapeutic outcomes.